Activation of coagulation and fibrinolysis in microsurgical reconstructions in the lower extremities

British Journal of Plastic Surgery

Volumn 54, Issue 7, 2001, Pages 597-603

  Olsson, Eija Helena ^a,c   Svartling, Nils ^b   Asko Seljavaara, Sirpa ^b   Lassila, Riitta ^b,c  

^a Section of Rheumatology   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Coagulation; Fibrinolysis; Microsurgery; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CORTISONE; D DIMER; DALTEPARIN; FIBRINOGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN COMPLEX; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ANASTOMOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FIBRINOLYSIS; GRAFT FAILURE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LEG INJURY; LEG ULCER; MALE; MICROSURGERY; PREDICTION; PRIORITY JOURNAL; REOPERATION; SURGERY; THROMBOSIS; TIME; TISSUE NECROSIS;

EID: 0034768851     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjps.2001.3687     Document Type: Article

References (36)

1. Analysis of 200 free flaps
2. Free flap surgery: The Welsh Regional Unit experience
3. Avoiding free flap failure
4. Free flap failures
5. Thrombus formation in microvascular surgery: An experimental study of the effects of surgical trauma
6. Scanning electron microscopic observations on the endothelial healing mechanism of vessels
7. Microcirculatory disturbances following the passage of emboli in an experimental free-flap model
8. Free tissue failure is not an all-or-none phenomenon
9. Vascular complications after free tissue transfer
10. Platelet-mediated thrombosis in microvascular surgery: New knowledge and strategies
11. Comparison of markers of coagulation activation in patients under oral anticoagulation at different levels
12. The thrombo-embolic risk in surgery
13. Haemostatic response to trauma
14. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery
15. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide
16. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay
17. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis
18. Leiden fibrinolysis working party: Blood collection and handling procedures for assessment of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1)
19. Blood coagulation and fibrinolysis activation during sudden arterial occlusion of lower extremities - An association with ischemia and patient outcome
20. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism
21. D-dimers, thrombin-antithrombin III complexes and prothrombin fragments 1 + 2: Diagnostic value in clinically suspected deep vein thrombosis
22. Persistent generation of thrombin after acute myocardial infarction
23. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
24. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin
25. Activation of coagulation and fibrinolysis despite heparinization during successful elective coronary angioplasty
26. Hemostasis and fibrinolysis activation after subarachnoid hemorrhage
27. Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease
28. Blood coagulation activity during microsurgery
29. Immunohistochemical evaluation of failed vessel anastomoses in clinical microsurgery
30. Physiological mechanisms in coagulation and fibrinolysis
31. Serial changes in hemostasis after intracranial surgery
32. Haemostatic disturbances in burned patients during early excision and skin grafting
33. Coagulation changes during packed red cell replacement of major blood loss
34. Pentastarch may cause fewer effects on coagulation than hetastarch
35. Haemostatic changes caused by i.v. regional anaesthesia with lignocaine
36. Influence of heparin treatment on biochemical markers of an activation of the coagulation system